These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 12955350)

  • 1. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches.
    Adeyi OA; Girnita AL; Howe J; Marrari M; Awadalla Y; Askar M; Martell J; Zeevi A; Shapiro R; Nalesnik M; Randhawa P; Demetris AJ; Duquesnoy RJ
    Transpl Immunol; 2005 Mar; 14(1):53-62. PubMed ID: 15814283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
    Duquesnoy RJ
    Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptable HLA mismatches for highly immunized patients.
    Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
    Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients.
    Valentini RP; Nehlsen-Cannarella SL; Gruber SA; Mattoo TK; West MS; Lang C; Imam AA
    Pediatr Transplant; 2007 Feb; 11(1):77-81. PubMed ID: 17239127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty.
    Böhringer D; Reinhard T; Duquesnoy RJ; Böhringer S; Enczmann J; Lange P; Claas F; Sundmacher R
    Transplantation; 2004 Feb; 77(3):417-21. PubMed ID: 14966417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview and epitope matching.
    Terasaki PI; Park MS; Takemoto S; Cecka JM; Clark B; Corcoran S; Cicciarelli J; Barbetti A; Yuge J; Carnahan E
    Clin Transpl; 1989; ():499-516. PubMed ID: 2484860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
    Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-array antibody screening in detecting antibodies to mismatched HLA in patients awaiting a second transplant.
    Rosenberg JC; Berri R; Jackowski M; Levis D; Nehlsen-Cannarella S; Oh H
    Transplant Proc; 2006 Dec; 38(10):3393-5. PubMed ID: 17175281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.